Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

A Calgary company backed by Dragons’ Den star Arlene Dickinson that has consolidated optometry practices across Canada has raised a nine-figure sum from U.S. private equity giant L Catterton.

FYi Eye Care Services and Products Inc., led by eye-doctor-turned-chief-executive Alan Ulsifer, has built a network of 250 locations, with 500 optometrists and 2,700 employees and annual revenues exceeding $350-million. The company, operating as FYidoctors, makes its own eyeglass lenses at a facility in Delta, B.C.

“We love the brand,” said Andrew Taub, managing partner in L Catterton’s flagship buyout fund, which invests US$50-million to US$400-million a deal. The firm, based in Greenwich, Conn., has backed dozens of consumer-focused brands including Restoration Hardware Inc., Peloton Interactive Inc. and Outback Steakhouse owner Bloomin’ Brands Inc. It’s believed the amount invested in FYidoctors exceeds $100-million, although the parties did not disclose terms.

Story continues below advertisement

The optical market in Canada is “a super attractive category” worth $5.5-billion and growing about 4 per cent a year, Mr. Taub said. "It’s a good category, it does well in good times and bad, with nice growth prospects.”

FYi is the latest in a string of Alberta enterprises outside the energy sector to attract significant funding, including online giving software provider Benevity Inc., warehouse robotics firm Attabotics Inc. and learning software maker Absorb Software Inc.

At a time when Albertans are contending with the economic impact of chronically low oil and gas prices and the political challenges of getting those landlocked products to market, “we have to stop thinking about what was and what could be,” said Ms. Dickinson, an FYi investor and board member.

“I’m very sympathetic to the energy sector, but I’m not so sympathetic that I believe [political leaders] don’t need to get thinking about what the future is going to look like [and] what else can happen in the economy to help Alberta," Ms. Dickinson said. "FYidoctors is a great example of what’s possible.”

Dr. Ulsifer was operating one of Canada’s largest independent optometry practices in Grande Prairie, Alta., in the mid-2000s when he came up with the idea for FYi.

Advances in lens manufacturing technology were making it possible for customized manufacturing, and Dr. Ulsifer worried that independents would struggle competing with chain stores on pricing and technology. He persuaded other eye doctors to merge into a collaborative entity to fund their own manufacturing laboratory and distribution centre. By centralizing marketing, administration and training, they could achieve economies of scale and stay in-step with industry changes.

FYi launched in April, 2008, with 120 doctors and 74 locations from British Columbia to Nova Scotia, making it Canada’s second-largest eye care provider behind LensCrafters parent Luxottica Group SpA. Five years later, when FYi had 107 locations, Dr. Ulsifer was named Entrepreneur of the Year by Ernst & Young.

Story continues below advertisement

The company is owned by eye doctors, who sell their practices to FYi in exchange for cash and shares in the company. They will continue to collectively own a majority after the financing. In addition, half of the board is made up of optometrists. “Our goal was never just to bring together companies for the purposes of a flip," Dr. Ulsifer said, "but to build an iconic brand … really focused on eye health.”

Constrained in its growth by internal cash flows and lines of credit, the company had relied on word-of-mouth to bring in new doctors. That will change, Dr. Ulsifer said, noting there are more than 2,000 practices across Canada with the potential to join FYi, as well as expansion opportunities in the United States. “With this funding our plan is to go to market and knock on doors, which is not the approach we’ve taken historically. There’s a huge opportunity in the Canadian market [backed by] a proven brand builder” in L Catterton.

Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening. Sign up today.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies